Bacil Pharma Enterprise Value (EV)

Bacil Pharma Ltd Enterprise Value

The Bacil Pharma Ltd Enterprise Value is a key financial metric used by investors to evaluate Bacil Pharma Ltd's valuation, profitability, and overall financial performance. Tracking the Bacil Pharma Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Bacil Pharma Ltd (NSE: , BSE: 524516) is currently trading at ₹13.23, with a market capitalization of ₹18.08Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Bacil Pharma Ltd Enterprise Value is essential for fundamental analysis.

Bacil Pharma Ltd Enterprise Value Current Value

The current Bacil Pharma Ltd Enterprise Value stands at 0.

The Bacil Pharma Ltd Enterprise Value remains stable, indicating consistent financial performance.

Bacil Pharma Ltd Enterprise Value Historical Trend

The Bacil Pharma Ltd Enterprise Value has shown the following historical trend:

The decline in Bacil Pharma Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.

What Bacil Pharma Ltd Enterprise Value Indicates for Investors

The Bacil Pharma Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Bacil Pharma Ltd.

Bacil Pharma Ltd Enterprise Value Analysis Summary

The Bacil Pharma Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Bacil Pharma Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Bacil Pharma Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.